Harmony Biosciences Holdings (HRMY)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Net income (ttm)	US$ in thousands	128,853	150,755	200,237	189,468	181,468	155,673	58,110	48,696	34,597	11,675	23,204
Total assets	US$ in thousands	811,448	777,766	760,183	715,092	673,870	643,464	505,034	464,005	433,443	391,092	359,695	337,252	427,074	320,073
ROA		15.88%	19.38%	26.34%	26.50%	26.93%	24.19%	11.51%	10.49%	7.98%	2.99%	6.45%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $128,853K ÷ $811,448K
= 15.88%

Harmony Biosciences Holdings Inc's return on assets (ROA) has exhibited fluctuations in recent quarters. The company's ROA experienced a notable increase in Q3-Q4 2022, peaking at 26.93%. However, in the subsequent quarters of 2023, the ROA has shown a decrease, with Q4 2023 recording a ROA of 15.88%. Overall, Harmony Biosciences Holdings Inc's ROA has shown variability, indicating changes in the company's ability to generate earnings relative to its total assets. Further analysis of the company's financial performance and asset management strategies would be necessary to fully understand the reasons behind the observed fluctuations in ROA.